GM

Geratherm Medical AGXETRA Geratherm Stock Report

Last reporting period 30 Jun, 2024

Updated 18 Sep, 2024

Last price

Market cap $B

0.023

Micro

Exchange

XETR - Xetra

GME.DE Stock Analysis

GM

Uncovered

Geratherm Medical AG is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

13/100

Low score

Market cap $B

0.023

Dividend yield

6.38 %

Shares outstanding

5.445 B

Geratherm Medical AG engages in the manufacture and distribution of medical technology products used for temperature management and medical diagnostics. The company is headquartered in Geschwenda, Thueringen and currently employs 204 full-time employees. The company went IPO on 2000-07-03. The firm operates through four segments: Healthcare Diagnostic, Medical Warming Systems, Cardio/Stroke and Respiratory. The Healthcare Diagnostic segment provides analog and digital products for measuring body temperature, blood pressure monitors and other products for measuring temperature, as well as related accessories. The Medical Warming Systems provides solutions for temperature management at all stages in the pre-clinical and clinical care of the patients, such as rescue situations and operations. The Cardio/Stroke segment comprises products for preventing strokes. The Respiratory segment focuses on the development and production of products for pulmonary functional diagnostics.

View Section: Eyestock Rating